Testing BLU-5937 for hard-to-treat chronic cough
Part of Lungs & breathing clinical trials.
This 24-week study tests whether a new medicine called BLU-5937 can help adults whose chronic cough hasn't improved with standard treatments. Chronic cough that lasts a year or longer can seriously affect quality of life, and this trial explores whether this drug might provide relief.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a chronic cough lasting at least one year that hasn't responded well to typical treatments
- You are not currently smoking or vaping (any form), and haven't smoked in the past 6 months
- You don't have COPD, bronchiectasis, cystic fibrosis, uncontrolled asthma, or other major lung diseases that cause cough
- You haven't had a respiratory infection (like bronchitis or pneumonia) in the past 4 weeks
- If you can become pregnant, you agree to use reliable birth control during the study and for 2 weeks after
- You haven't had cancer in the past 5 years, and don't have untreated HIV, hepatitis B, or hepatitis C
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine, HW091077, for people who have had a chronic cough for at least a year that hasn't gotten better with treatment or has no clear cause. It aims to see if the drug can help reduce coughing.
This trial tests whether an extended-release medication called nalbuphine can reduce coughing in people with chronic cough that hasn't improved with other treatments. You may be eligible if you've had a persistent cough for at least a year and have already tried treatments for conditions that could cause it.
This study tests a behavior-based therapy to help you gain control over a persistent cough that hasn't responded to other treatments. You will learn techniques to reduce coughing during a 4-week program.
This study tests a behavioral therapy delivered through group video calls to help people with a chronic dry cough that has no clear cause. It may offer a non-drug way to reduce coughing.
This trial tests a smartphone app and a smartwatch to help people with chronic cough that hasn't improved with standard care. You'll wear a watch to track your cough and use the app to learn management techniques.
This Phase 2 study tests whether two doses of duloxetine and amitriptyline can reduce symptoms in people with chronic cough that hasn’t responded to usual care. You may join to see if these medicines lessen cough severity over an 8-week blinded treatment period.
Hear when a new Refractory Chronic Cough trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.